Prospective Randomized OPEN Trial Designed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in DE NOVO Kidney Transplant Recipients Two-Year Results.

被引:0
|
作者
Esmeraldo, R. [1 ]
Oliveira, M. [1 ]
Pinheiro, P. [1 ]
Girao, C. [1 ]
Freitas, T. [1 ]
机构
[1] Hosp Geral Fortaleza, Transplant, Fortaleza, Ceara, Brazil
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
39
引用
收藏
页码:218 / 218
页数:1
相关论文
共 50 条
  • [1] ONE-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED OPEN TRIAL DESIGNED TO REDUCE THE INCIDENCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Esmeraldo, Ronaldo
    Mb Oliveira, Maria Luiza
    Pinheiro, Petrucia Ma
    Girao, Celi M.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 2 - 2
  • [2] A Prospective Randomized Trial Aimed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant Recipients
    Tedesco, H.
    Felipe, C.
    Sandes-Freitas, T.
    Oliveira, N.
    Gusukuma, L.
    Ferreira, A.
    Cristelli, M.
    Franco, M.
    Medina-Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 765 - 765
  • [3] A Prospective Randomized Trial Aimed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant Recipients
    Tedesco, H.
    Felipe, C.
    Sandes, T.
    Cristelli, M.
    Rodrigues, C.
    Pestana, J. O. M.
    TRANSPLANTATION, 2012, 94 (10) : 4 - 4
  • [4] A Prospective Randomized Trial Aimed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant Recipients.
    Tedesco, H.
    Felipe, C.
    Sandes-Freitas, T.
    Oliveira, N.
    Gusukuma, L.
    Ferreira, A.
    Cristelli, M.
    Franco, M.
    Medina-Pestana, J.
    TRANSPLANTATION, 2014, 98 : 765 - 765
  • [5] A PROSPECTIVE RANDOMIZED TRIAL AIMED TO REDUCE THE INCIDENCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN KIDNEY TRANSPLANT (KT) RECIPIENTS
    Tedesco-Silva, Helio
    Sandes-Freitas, Taina
    Felipe, Claudia
    Cristelli, Marina
    Rodrigues, Carolina
    Gusukuma, Luciana
    Medina-Pestana, Jose Osmar
    TRANSPLANT INTERNATIONAL, 2013, 26 : 154 - 155
  • [6] A Prospective Randomized Trial Aimed To Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant (KT) Recipients
    Tedesco, H.
    Felipe, C.
    Wang, L.
    Rodrigues, C.
    Sandes, T.
    Cristelli, M.
    Franco, M.
    Medina-Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 56 - 56
  • [7] A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
    Hill, James A.
    Hummel, Manfred
    Starling, Randall C.
    Kobashigawa, Jon A.
    Perrone, Sergio V.
    Arizon, Jose M.
    Simonsen, Svein
    Abeywickrama, Kamal H.
    Bara, Christoph
    TRANSPLANTATION, 2007, 84 (11) : 1436 - 1442
  • [8] Ketoconazole-tacrolimus coadministration in kidney transplant recipients: Two-year results of a prospective randomized study
    El-Dahshan, Khalid Farouk
    Bakr, Mohamed Adel
    Donia, Ahmed Farouk
    Badr, Ali El-Sayed
    Sobh, Mohamed Abdel-Kader
    AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (03) : 293 - 298
  • [9] Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial
    Viana, Laila Almeida
    Cristelli, Marina Pontello
    Basso, Geovana
    Santos, Daniel Wagner
    Costa Dantas, Marcus Taver
    Dreige, Yasmim Cardoso
    Requio Moura, Lucio R.
    Nakamura, Monica Rika
    Medina-Pestana, Jose
    Tedesco-Silva, Helio
    TRANSPLANTATION, 2023, 107 (08) : 1835 - 1845
  • [10] Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial
    Roberts, Matthew B.
    Kotton, Camille N.
    TRANSPLANTATION, 2024, 108 (04) : E63 - E63